In a previous study, targeted capture sequencing of selected 34 genes in 215 DLBCL patients revealed that TNFAIP3 and GNA13 mutations were significantly associated with poorer prognosis in ABC-like DLBCL patients subjected to R-CHOP treatment [10]. Here, DDIT3 is linked to diffuse large B-cell lymphoma.